Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Tumour circulating cells

ELCC 2010

28 Apr - 1 May 2010

Published: 8 Jun 2010

Views: 9634

Rating:

Save

Prof Julien Mazieres - University Hospital, Toulouse

Prof Julien Mazieres, speaking at the 2010 ELCC conference, discusses tumour circulating cells; the importance of these cells as a prognostic factor and the challenges faced and techniques used to isolate them.

Related Videos

Low-dose CT screening reduces lung cancer mortality and improves survival in broad populations

Dr Caichen Li - Guangzhou Medical University, Guangzhou, China

Low-dose CT screening reduces lung cancer mortality and improves survival in broad populations ( Dr Caichen Li - Guangzhou Medical University, Guangzhou, China )

MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection

Dr Nima Nabavizadeh - Oregon Health & Science University, Portland, USA

MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection ( Dr Nima Nabavizadeh - Oregon Health & Science University, Portland, USA )

New classification for identifying HR myeloma based on cytogenetic abnormalities

Dr Jill Corre - IUCT Oncopole, Toulouse, France

New classification for identifying HR myeloma based on cytogenetic abnormalities ( Dr Jill Corre - IUCT Oncopole, Toulouse, France )

Tele-mentoring: Impact of project ECHO

Dr Sanjeev Arora - Project ECHO, Albuquerque, USA

Tele-mentoring: Impact of project ECHO ( Dr Sanjeev Arora - Project ECHO, Albuquerque, USA )

Predicting tumour mutations from pathology images may help increase personalised medicine utilisation

Dr Rom Leidner - Providence Cancer Institute, Portland, USA

Predicting tumour mutations from pathology images may help increase personalised medicine utilisation ( Dr Rom Leidner - Providence Cancer Institute, Portland, USA )

Cancer mutation prediction using artificial intelligence

Dr Carlo Bifulco - Providence Cancer Institute, Southfield, USA

Cancer mutation prediction using artificial intelligence ( Dr Carlo Bifulco - Providence Cancer Institute, Southfield, USA )

ESMO 2024: Optimising the personalisation of prostate cancer treatment

Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg

ESMO 2024: Optimising the personalisation of prostate cancer treatment ( Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg )

Psychological issues in familial cancer

Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India

Psychological issues in familial cancer ( Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India )

ASCO 2024: Lung cancer highlights

Dr Antonio Passaro, Dr Matthew Krebs, Prof Raffaele Califano, Prof Nicolas Girard and Dr Anna Minchom

ASCO 2024: Lung cancer highlights ( Dr Antonio Passaro, Dr Matthew Krebs, Prof Raffaele Califano, Prof Nicolas Girard and Dr Anna Minchom )

More from ecancer